Found: 20
Select item for more details and to access through your institution.
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.
- Published in:
- Oncogene, 2009, v. 28, n. 44, p. 3866, doi. 10.1038/onc.2009.257
- By:
- Publication type:
- Article
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.
- Published in:
- Oncogene, 2006, v. 25, n. 54, p. 7180, doi. 10.1038/sj.onc.1209699
- By:
- Publication type:
- Article
Enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy.
- Published in:
- Bone Marrow Transplantation, 2001, v. 28, n. 4, p. 335, doi. 10.1038/sj.bmt.1703134
- By:
- Publication type:
- Article
Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell lines.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Expression and cellular distribution pattern of plasma membrane calcium pump isoforms in rat pancreatic islets.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6.
- Published in:
- Clinical & Experimental Immunology, 1994, v. 98, n. 2, p. 323
- By:
- Publication type:
- Article
Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experience.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 936, doi. 10.1038/bmt.2010.231
- By:
- Publication type:
- Article
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m<sup>2</sup>) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 4, p. 275, doi. 10.1038/sj.bmt.1705441
- By:
- Publication type:
- Article
Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m<sup>2</sup> of melphalan in multiple myeloma: results of a pilot study including biological aspects.
- Published in:
- Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 771, doi. 10.1038/sj.bmt.1705138
- By:
- Publication type:
- Article
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Prospective Randomized Study Comparing MEMID with a Chop-Like Regimen in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma.
- Published in:
- Oncology, 2005, v. 69, n. 1, p. 19, doi. 10.1159/000087284
- By:
- Publication type:
- Article
Origin of malignant centrofacial granulomas: Surface markers and gene rearrangement of malignant cells.
- Published in:
- Laryngoscope, 1991, v. 101, n. 9, p. 998, doi. 10.1288/00005537-199109000-00012
- By:
- Publication type:
- Article